Trailing-twelve-month (TTM) revenue is $78.01 Billion with a year-over-year growth of +7.31%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $19,161,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $19,513,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-10 |
| Q1 FY2026Period ended 2026-03-31 | $19,109,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-29 |
| Q2 FY2026Period ended 2026-06-30 | $20,230,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-28 |
| TTM revenue | $78,013,000,000 |
Current P/S: $91,911,382,380 market capitalization ÷ $78,013,000,000 TTM revenue = 1.18x.
Market capitalization source: FMP quote. Quote observed 2026-09-15T15:55:13.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $20.23B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-15T15:55:46.151Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| International | $1.1B | $1.3B | $1.3B | $1.5B | $1.7B | $1.9B |
| Managed Care And Other Insurers | $26.5B | $30.3B | $29.1B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| American Group | $23.6B | $26.2B | $26.9B | $22.3B | $24.6B | $26.4B |
| Atlantic Group | N/A | N/A | N/A |
$78.01B
$78.01 Billion
+7.31%
vs. $72.70B a year ago (TTM)
+6.85%
5 Year compound annual growth rate
1 Year
+7.31%
3 Year
+8.00%
5 Year
+6.85%
10 Year
+6.73%
15 Year
+6.23%
20 Year
+5.86%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $75.60B | +$5.00B | +7.08% |
| 2024 | $70.60B | +$5.63B | +8.67% |
| 2023 | $64.97B | +$4.74B | +7.86% |
| 2022 | $60.23B | +$1.48B | +2.52% |
| 2021 | $58.75B | +$7.22B | +14.01% |
| 2020 |
TTM Growth
+7.31%
3-Year CAGR
+8.00%
5-Year CAGR
+6.85%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-15T15:55:46.151Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $35.0B |
| $37.0B |
| Managed Medicaid | $2.6B | $3.1B | $4.0B | $3.9B | $4.0B | $3.7B |
|---|
| Managed Medicare | $7.0B | $8.4B | $9.2B | $10.5B | $12.0B | $13.4B |
|---|
| Medicaid | $2.0B | $2.3B | $2.6B | $3.6B | $4.7B | $5.9B |
|---|
| Medicare | $10.4B | $10.4B | $10.4B | $10.6B | $10.8B | $11.3B |
|---|
| $23.2B |
| $24.7B |
| Corporate and Other | $2.2B | $2.8B | $3.0B | $3.4B | N/A | N/A |
|---|
| National Group | $25.7B | $29.8B | $30.4B | $18.1B | $19.6B | $21.3B |
|---|
| $51.53B |
| +$197.00M |
| +0.38% |
| 2019 | $51.34B | +$4.66B | +9.98% |
| 2018 | $46.68B | +$3.06B | +7.02% |
| 2017 | $43.61B | +$2.12B | +5.12% |
| 2016 | $41.49B | +$1.81B | +4.57% |
